D
BioHarvest Sciences Inc. BHSC
CNSX
Recommendation
Sell
Prev Close
$7.95
Volume
--
Avg Vol (90D)
3,536
Market Cap
$97.08M
Dividend & Yield
--
52-Week Range
$6.24 - $10.50
P/E (TTM)
--
EPS (TTM)
-$1.19
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$22.43M
EBITDA (TTM)
-$6.84M
EBIT (TTM)
-$7.85M
Net Income (TTM)
-$17.19M
Balance Sheet
Total Assets (Q)
$25.82M
Total Debt (Q)
$10.70M
Total Liabilities (Q)
$21.68M
Book Value Per Share (Q)
$0.2389
Cash Flow
Cash from Operations (TTM)
-$7.29M
Cash from Investing (TTM)
-$2.92M
Cash from Financing (TTM)
$11.34M
Net Change in Cash (TTM)
$1.21M
Filings
Filing Date
Monday, November 25, 2024
Period Date
Monday, September 30, 2024
Next Filing
End of April (est)
Price History
Loading...
Beta
0.76
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Oct 29, 2024 - $6.24
52-week High
Mar 19, 2024 - $10.50
Valuation
Market Cap
$97.08M - Micro Cap
Enterprise Value
$104.63M
Price/Sales (TTM)
6.15
Price/Book (Q)
33.28
Dividends and Shares
Shares Outstanding
17.34M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.bioharvest.com
Phone Number
604 622 1186
Address
1140-625 Howe Street
Vancouver, BC V6C 2T6
Country
Canada
Year Founded
--
Business Description
Sector
Consumer Staples
Industry
Household and Personal Products
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow... more
Weiss Ratings